Grantham, Mayo, Van Otterloo & Co (GMO)’s Associated Banc-Corp ASB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$264K Sell
10,200
-5,340
-34% -$142K ﹤0.01% 599
2025
Q4
$400K Hold
15,540
﹤0.01% 595
2025
Q3
$400K Sell
15,540
-32,261
-67% -$827K ﹤0.01% 543
2025
Q2
$1.17M Buy
47,801
+33,560
+236% +$756K ﹤0.01% 454
2025
Q1
$321K Sell
14,241
-22
-0.2% -$528 ﹤0.01% 571
2024
Q4
$341K Sell
14,263
-4,873
-25% -$119K ﹤0.01% 527
2024
Q3
$412K Hold
19,136
﹤0.01% 499
2024
Q2
$405K Buy
19,136
+3,611
+23% +$76K ﹤0.01% 462
2024
Q1
$334K Hold
15,525
﹤0.01% 462
2023
Q4
$332K Buy
15,525
+1,008
+7% +$18.1K ﹤0.01% 438
2023
Q3
$248K Sell
14,517
-136,779
-90% -$2.41M ﹤0.01% 538
2023
Q2
$2.46M Sell
151,296
-40,545
-21% -$669K 0.01% 422
2023
Q1
$3.45M Sell
191,841
-12,100
-6% -$265K 0.02% 370
2022
Q4
$4.71M Sell
203,941
-87,200
-30% -$2.01M 0.03% 344
2022
Q3
$5.85M Sell
291,141
-271,800
-48% -$5.47M 0.03% 312
2022
Q2
$10.3M Sell
562,941
-15,674
-3% -$317K 0.06% 257
2022
Q1
$13.2M Sell
578,615
-53,200
-8% -$1.29M 0.06% 220
2021
Q4
$14.3M Buy
631,815
+7,135
+1% +$161K 0.07% 207
2021
Q3
$13.4M Buy
624,680
+68,300
+12% +$1.39M 0.07% 214
2021
Q2
$11.4M Buy
556,380
+19,320
+4% +$427K 0.06% 235
2021
Q1
$11.5M Buy
537,060
+96,741
+22% +$1.96M 0.06% 222
2020
Q4
$7.51M Buy
440,319
+173,219
+65% +$2.63M 0.05% 234
2020
Q3
$3.37M Buy
267,100
+252,900
+1,781% +$3.35M 0.02% 307
2020
Q2
$194K Buy
+14,200
New +$193K ﹤0.01% 710
2020
Q1
Sell
-100,000
Closed -$2.2M 750
2019
Q4
$2.2M Sell
100,000
-15,900
-14% -$336K 0.01% 382
2019
Q3
$2.35M Sell
115,900
-66,300
-36% -$1.34M 0.02% 400
2019
Q2
$3.85M Buy
182,200
+102,900
+130% +$2.23M 0.03% 342
2019
Q1
$1.69M Sell
79,300
-15,500
-16% -$342K 0.01% 412
2018
Q4
$1.88M Buy
94,800
+11,700
+14% +$268K 0.02% 286
2018
Q3
$2.16M Buy
+83,100
New +$2.27M 0.01% 300

Other funds holding ASB

Grantham, Mayo, Van Otterloo & Co (GMO)'s ASB Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Associated Banc-Corp (ASB) stake by 34% in Q1 2026, selling an estimated $142K and leaving 10,200 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #599.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ASB in Q3 2018 and has held it in 30 quarters since. The position peaked at $14.3M in Q4 2021. 368 funds tracked by Wall St. Rank hold ASB as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 10,200 shares of Associated Banc-Corp worth $264K as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 5,340 Associated Banc-Corp shares in Q1 2026, an estimated $142K.
  • Associated Banc-Corp made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #599 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Associated Banc-Corp in Q3 2018 and has held it in 30 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Associated Banc-Corp position peaked at $14.3M in Q4 2021.
  • 368 funds tracked by Wall St. Rank held Associated Banc-Corp as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.